OrganiGram (OGI)
(Delayed Data from NSDQ)
$1.86 USD
0.00 (0.00%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $1.87 +0.01 (0.54%) 7:58 PM ET
2-Buy of 5 2
C Value C Growth D Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
OGI 1.86 0.00(0.00%)
Will OGI be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for OGI based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for OGI
Are Medical Stocks Lagging OrganiGram (OGI) This Year?
Why OrganiGram (OGI) Might Surprise This Earnings Season
OGI: What are Zacks experts saying now?
Zacks Private Portfolio Services
Rockwell Medical (RMTI) Reports Q3 Loss, Tops Revenue Estimates
Organigram (OGI) Grows in Cannabis Space With SHRED X Heavies
Canopy Growth Corporation (CGC) Reports Q4 Loss, Lags Revenue Estimates
Other News for OGI
The Top 3 Cannabis Stocks to Buy in April 2024
OrganiGram Holdings Announces Auditor Change
Cannabis Stock Movers For April 22, 2024
Organigram Is My Favorite Cannabis Stock Again
Organigram: Operating In A Structurally Challenged Industry